BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38060444)

  • 1. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors.
    Wang L; Tan TK; Kim H; Kappei D; Tan SH; Look AT; Sanda T
    Cell Rep; 2023 Dec; 42(12):113541. PubMed ID: 38060444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
    Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
    Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioneer factor ASCL1 cooperates with the mSWI/SNF complex at distal regulatory elements to regulate human neural differentiation.
    Păun O; Tan YX; Patel H; Strohbuecker S; Ghanate A; Cobolli-Gigli C; Llorian Sopena M; Gerontogianni L; Goldstone R; Ang SL; Guillemot F; Dias C
    Genes Dev; 2023 Mar; 37(5-6):218-242. PubMed ID: 36931659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
    van Groningen T; Akogul N; Westerhout EM; Chan A; Hasselt NE; Zwijnenburg DA; Broekmans M; Stroeken P; Haneveld F; Hooijer GKJ; Savci-Heijink CD; Lakeman A; Volckmann R; van Sluis P; Valentijn LJ; Koster J; Versteeg R; van Nes J
    Nat Commun; 2019 Apr; 10(1):1530. PubMed ID: 30948783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the developmental origin of neuroblastoma: an overview.
    Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
    J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors.
    Jahangiri L; Pucci P; Ishola T; Pereira J; Cavanagh ML; Turner SD
    Discov Oncol; 2021 Nov; 12(1):56. PubMed ID: 35201514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.
    Huang Y; Tsubota S; Nishio N; Takahashi Y; Kadomatsu K
    Cancer Sci; 2021 Feb; 112(2):715-724. PubMed ID: 33277754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
    Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30735. PubMed ID: 37859597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.
    Kasim M; Benko E; Winkelmann A; Mrowka R; Staudacher JJ; Persson PB; Scholz H; Meier JC; Fähling M
    J Biol Chem; 2014 Sep; 289(39):26973-26988. PubMed ID: 25124043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma.
    Parkinson LM; Gillen SL; Woods LM; Chaytor L; Marcos D; Ali FR; Carroll JS; Philpott A
    Front Cell Dev Biol; 2022; 10():942579. PubMed ID: 36263020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma.
    Ali FR; Marcos D; Chernukhin I; Woods LM; Parkinson LM; Wylie LA; Papkovskaia TD; Davies JD; Carroll JS; Philpott A
    Mol Cancer Res; 2020 Dec; 18(12):1759-1766. PubMed ID: 33046535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
    Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37693610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.
    Yu EY; Zahid SS; Aloe S; Falck-Pedersen E; Zhou XK; Cheung NV; Lue NF
    Commun Biol; 2021 Nov; 4(1):1315. PubMed ID: 34799676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
    Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
    Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2).
    Li J; Neumann I; Volkmer I; Staege MS
    Mol Biol Rep; 2011 Mar; 38(3):1515-21. PubMed ID: 20842449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma.
    Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A
    Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression.
    Hu T; Zeng C; Song Z; Liu Q; Chen S; Huang W; Ma Q; Li H
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167050. PubMed ID: 38331110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.
    Decaesteker B; Louwagie A; Loontiens S; De Vloed F; Bekaert SL; Roels J; Vanhauwaert S; De Brouwer S; Sanders E; Berezovskaya A; Denecker G; D'haene E; Van Haver S; Van Loocke W; Van Dorpe J; Creytens D; Van Roy N; Pieters T; Van Neste C; Fischer M; Van Vlierberghe P; Roberts SS; Schulte J; Ek S; Versteeg R; Koster J; van Nes J; Zimmerman M; De Preter K; Speleman F
    Nat Commun; 2023 Mar; 14(1):1267. PubMed ID: 36882421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated ASCL1 activity creates de novo regulatory elements associated with neuronal differentiation.
    Woods LM; Ali FR; Gomez R; Chernukhin I; Marcos D; Parkinson LM; Tayoun ANA; Carroll JS; Philpott A
    BMC Genomics; 2022 Apr; 23(1):255. PubMed ID: 35366798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcription factor network specifying inhibitory versus excitatory neurons in the dorsal spinal cord.
    Borromeo MD; Meredith DM; Castro DS; Chang JC; Tung KC; Guillemot F; Johnson JE
    Development; 2014 Jul; 141(14):2803-12. PubMed ID: 24924197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.